Flubendazole: A candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs

Expert Review of Anti-Infective Therapy

Volumn 9, Issue 5, 2011, Pages 497-501

  Mackenzie, Charles D ^a   Geary, Timothy G ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

filariasis; global control programs; macrofilaricides; onchocerciasis

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALBENDAZOLE; BENZIMIDAZOLE DERIVATIVE; DIETHYLCARBAMAZINE; FLUBENDAZOLE; IVERMECTIN; MEBENDAZOLE;

ANIMAL DISEASE; CONCENTRATION RESPONSE; DRUG BIOAVAILABILITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; EDITORIAL; ELEPHANTIASIS; EMBRYOTOXICITY; FILARIASIS; GASTROINTESTINAL INFECTION; HUMAN; INJECTION SITE REACTION; LIPOPHILICITY; LOW DRUG DOSE; LYMPHATIC FILARIASIS; MICROFILARIASIS; NONHUMAN; ONCHOCERCIASIS; PARASITE CONTROL; PARASITE SURVIVAL; TREATMENT RESPONSE;

ANIMALS; ANTHELMINTICS; BETA-CYCLODEXTRINS; BRUGIA; CHEMISTRY, PHARMACEUTICAL; DIETHYLCARBAMAZINE; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; EXCIPIENTS; FILARICIDES; HUMANS; IVERMECTIN; MEBENDAZOLE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS;

EID: 79957608338     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.11.30     Document Type: Editorial

References (24)

1. Hopkins AD. Ivermectin and onchocerciasis: is it all solved? Eye (Lond.) 19, 1057-1066 (2005).
2. Geary TG, Woo K, McCarthy JS et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 40, 1-13 (2009).
3. Delatour P, Richard Y. The embryotoxic and antimitotic properties of a series of benzimidazoles. Therapie 31, 505-515 (1976).
4. Lacey E. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of drug resistance to benzimidazoles. Int. J. Parasitol. 7, 885-936 (1988). Describes the important preference of benzimidazoles for parasite tubulin over mammalian tubulin.
5. Bradley RE, Guerrero J, Becker HN, Michael BF, Newcomb K. Flubendazole: dose range and efficacy studies against common internal parasites of swine. Am. J. Vet. Res. 7, 1329-1333 (1983).
6. Dominguez-Vasquez A, Taylor HR, Greene BM et al. Comparison of flubendazole and diethylcarbamazine in treatment of onchocerciasis. Lancet 1(8317), 139-143 (1983). The first study of flubendazole in human filariasis identified this agent as a potentially important macrofilaricide.
7. Denham DA, Samad R, Cho SY, Suswillo RR, Skippins SC. The anthelmintic effects of flubendazole on Brugia pahangi. Trans. R. Soc. Trop. Med. Hyg. 73, 673-676 (1979). Suggests that flubendazole may preferentially kill adult filarial worms and be much less effective against the microfilarial stage.
8. Denham DA, Brandt E. Chemoprophylactic activity of flubendazole against adult Brugia pahangi transplanted into the peritoneal cavity of jirds. J. Parasitol. 66, 933-934 (1980).
9. Mackenzie CD, Geary TG, Gerlach JA. Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients. Filaria J. 2(Suppl. 1) S5 (2003).
10. Ceballos L, Elissondo M, Bruni SS, Denegri G, Alvarez L, Lanusse C. Flubendazole in cystic echinococcosis therapy: pharmaco - parasitological evaluation in mice. Parasitol. Int. 58, 354-358 (2009). First showed the effectiveness of a new oral formulation of flubendazole against a tissue-dwelling helminth parasite.
11. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech 6(2), E329-E357 (2005).
12. Rigter IM, Schipper HG, Koopmans RP et al. Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers. Antimicrob. Agents Chemother. 48, 1051-1054 (2004).
13. Lahiani-Skiba M, Coquard A, Bounoure F, Verite P, Arnaud P, Skiba M. Mebendazole complexes with various cyclodextrins: preparation and physicochemical characterization. J. Inclus. Phenom. Macrocycl. Chem. 57, 197-201 (2007).
14. Pax RA, Williams JF, Guderian RH. In vitro motility of isolated adults and segments of Onchocerca volvulus, Brugia pahangi and Acanthocheilonema viteae. Trop. Med. Parasitol. 39(Suppl. 4), 450-455 (1988).
15. Satti MZ, VandeWaa EA, Bennett JL, Williams JF, Conder GA, McCall JW. Comparative effects of anthelmintics on motility in vitro of Onchocerca gutterosa, Brugia pahangi and Acanthocheilonema viteae. Trop. Med. Parasitol. 39(Suppl. 4), 480-483 (1988).
16. Hanser E, Mehlhorn H, Hoeben D, Vlaminck K. In vitro studies on the effects of flubendazole against Toxocara canis and Ascaris suum. Parasitol. Res. 89, 63-74 (2003).
17. Gyapong JO, Chinbuah MA, Gyapong M. Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis. Trop. Med. Int. Health 8, 1093-1101 (2003). Demonstrates that some benzimidazoles may be safe in pregnant women despite the known antimitotic effects in vitro and in experimental animals.
18. Kinnamon KE, Klayman DL, Poon BT, McCall JW, Dzimianski MT, Rowan SJ. Filariasis testing in a jird model: new drug leads from some old standbys. Am. J. Trop. Med. Hygienne 51, 791-796 (1994).
19. Surin J, Denham DA. Comparative susceptibility to anthelmintics of Brugia pahangi in jirds infected by different methods. J. Helminthol. 64, 232-238 (1990).
20. Maeda R, Hayashi Y, Shibuya T. Basic studies on the laboratory assessment of macrofilaricides using Brugia malayi in the jird, Meriones unguiculatus. 2. Establishment and evaluation of a new method of macrofilaricide assessment. Japan. J. Exp. Med. 58, 45-49 (1988).
21. Devaney E, Howells RE, Smith G. Brugia pahangi in the BALB/C mouse: a model for testing filaricidal compounds. J. Helminthol. 59, 95-99 (1985).
22. Denham DA. Anthelmintic properties of flubendazole against Dipetalonema viteae in jirds. Trans. R Soc. Trop. Med. Hyg. 74, 829 (1980).
23. Zahner H, Schares G. Experimental chemotherapy of filariasis: comparative evaluation of the efficacy of filaricidal compounds in Mastomys coucha infected with Litomosoides carinii, Acanthocheilonema viteae, Brugia malayi and B. pahangi. Acta Tropica 52, 221-266 (1993).
24. Townson S, Dobinson A, Connelly C, Muller R. Chemotherapy of Onchocerca lienalis microfilariae in mice: a model for the evaluation of novel compounds for the treatment of onchocerciasis. J. Helminthol. 62, 181-194 (1988).